[Blood DNA radiosentivity as a predictive bindex of radiochemical treatment efficacy in cervical cancer patients] [0.03%]
[血DNA放射敏感性作为宫颈癌患者放射治疗疗效预测指标的分析]
S D Ivanov,I V Stolyarova,V A Yamshanov et al.
S D Ivanov et al.
Study of cervical cancer patients with I-III stage was performed with biomarker determination of the blood DNA radiosensitivity ex vivo. The biochemical index was measured before treatment start during 4 hours by use fluorescent dye. The re...
[Childbirth after treatment for breast cancer: experience of the P. A. Herzen Moscow Research oncology Institute] [0.03%]
乳腺癌治疗后分娩——莫斯科赫尔岑研究所的经验
A D Zakiryakhodzhaev,O V Novikova,E A Rasskazova
A D Zakiryakhodzhaev
The article presents an analysis of births after treatment for breast cancer in women of reproductive age. In details there is described this group of patients based on a retrospective analysis of case histories. Eight patients, included in...
[Chemotherapy and intraoperative radiation therapy for operable stage III non-small cell lung cancer] [0.03%]
可切除性三期非小细胞肺癌的化疗与术中放疗
A Y Dobrodeev,A A Zaviyalov,S A Tuzikov
A Y Dobrodeev
The study was undertaken to evaluate results of combined modality treatment including intraoperative radiation therapy (IORT) in 202 patients with stage III non-small cell lung cancer. The 5-year disease-free and overall survival rates in p...
[Kidney cancer with brain metastases. Prognostic factors and treatment outcome] [0.03%]
肾癌脑转移的预后因素和治疗效果
A V Golanov,S M Banov,E R Vetlova et al.
A V Golanov et al.
The aim of this study was to study the effectiveness of stereotactic radiosurgery by Gamma Knife in kidney cancer with brain metastases. There were analyzed results in 112 patients with such spread of the disease who received treatment in t...
[Leiomyosarcoma of soft tissues. Clinical characteristic and results of treatment] [0.03%]
软组织平滑肌肉瘤的临床特征和治疗结果
G I Gafton,V V Shchukin,M S Sinyachkin et al.
G I Gafton et al.
Clinical characteristics of leiomyosarcoma of soft tissues and results of treatment of patients with this pathology are presented. It was revealed that the peak of incidence was in the age group 5O-69 years. There was showed the priority of...
[Role of molecular-genetic abnormalities in pathogenesis and risk stratification of multiple myeloma] [0.03%]
分子遗传异常在多发性骨髓瘤发病机制和危险分层中的作用
A D Garifullin,I S Martynkevich,S V Voloshin et al.
A D Garifullin et al.
Over the past decades the studies have greatly improved our understanding of the molecular basis of multiple myeloma (MM) and mechanisms of disease progression. The majority of the most widespread chromosomal aberrations, revealing in MM, h...
[Diagnostic transcranial magnetic stimulation as a method of objective evaluation of motor pathways in patients with neoplastic and infectious brain damage] [0.03%]
诊断性经颅磁刺激作为评价肿瘤和感染所致脑损害患者运动通路客观方法的研究
V B Voitenkov,A V Kartashev,N V Skripchenko et al.
V B Voitenkov et al.
The aim of our study was to evaluate validity of transcranial magnetic stimulation as evaluation tool of motor pathways condition dynamics in patients with gliomas and meningitis. There were included 91 patients: 40 children with aseptic me...
[Dynamics of morbidity of patients with malignant tumors of the tongue with regard to the stage of disease and histological structure of tumors (population-based study)] [0.03%]
[舌部恶性肿瘤患者患病率的动态变化（基于人口的调查），考虑疾病阶段和肿瘤的组织学结构]
V M Merabishvili,A B Vasiliev,E N Merabishvili
V M Merabishvili
Introduction: Malignant tumors of the tongue (C-01. 02) are relatively rare visual tumor sites. Incidence rate in men is usually 4-5 times higher than in women. To estimate a complex of analytical rates with respect to ma...
V K Kosenok,L V Belskaya,Z Massard et al.
V K Kosenok et al.
Statistical patterns of breast cancer were studied in the Omsk Region in order to optimize early diagnosis and improve the effectiveness of treatment. It was found that the proportion of breast cancer patients in stage I in all age groups w...
K Liepe,V V Krylov,T Y Kochetova
K Liepe
The systemic radionuclide therapy with bone affinity substances is an effective therapy in bone palliative treatment. Studies with radiolabeled Bisphosphonate or strontium-89 show reduction of pain in 70-80% and about 20% of treated patient...